The group’s principal activity is to provide healthcare services. The group provides development and utilization technology for advanced wound care, orthopedic, cardiovascular and neurological conditions. The group products include Ossatron, Evotron, Dermapace, Versatron and Versatron4 Paws. The group operates from the United States.
